Fact checked by Jennifer Klump Despite its proven ability to prevent cancers, the HPV vaccine remains underused in the United ...

The program, created by Congress, allows people who believe they were injured by vaccines to apply for financial compensation ...

For her doctoral dissertation, Senior Planning Officer Idil Hussein studied the intentions of Finnish parents in terms of ...

Human papillomavirus (HPV) is the necessary cause of cervical cancer, which is the second most common cancer in women worldwide with over 493,000 new cases occurring in 2002. High vaccine efficacy ...

I currently test for human papillomavirus (HPV) DNA as a marker for HPV infection. With the advent of the HPV vaccine, how will clinicians be able to ...

National Cancer Registry reports an estimated 641 cases of new HPV-associated cancers diagnosed and 196 cancer deaths every ...

Human Papillomavirus (HPV)-induced Cancers: First Patient Enrolled in Phase I/IIa Clinical Trial for Lenti-HPV-07, the TheraVectys’ Therapeutic Vaccine Candidate Against Oropharyngeal and ...

Human papillomavirus (HPV) vaccines have long been central to reducing the global incidence of HPV‐associated cancers and benign lesions. Traditional vaccines, based on virus‐like particles ...

The APAC human papillomavirus (HPV) vaccine market is expected to grow from US$ 567.57 million in 2022 to US$ 826.34 million by 2028; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

New data from the CDC’s 2021 National Immunization Survey estimated that 80.9% of teens in Utah have received their first dose of the human papillomavirus vaccine.

Aluminum is among the vaccine ingredients facing scrutiny, but new findings underscore its safety for children and offer ...

The NHS has launched a catch-up campaign for the jab, which is key to eliminating cervical cancer in the UK by 2040 ...